Global Anthrax Vaccines Market Insights, Forecast to 2025
SKU ID :QYR-13101618 | Published Date: 15-Feb-2019 | No. of pages: 127Description
TOC
Table of Contents
1 Study Coverage
1.1 Anthrax Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anthrax Vaccines Market Size Growth Rate by Product
1.4.2 Live Vaccines
1.4.3 Cell free PA Vaccines
1.5 Market by End User
1.5.1 Global Anthrax Vaccines Market Size Growth Rate by End User
1.5.2 Human Use
1.5.3 Animal Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Market Size
2.1.1 Global Anthrax Vaccines Revenue 2014-2025
2.1.2 Global Anthrax Vaccines Sales 2014-2025
2.2 Anthrax Vaccines Growth Rate by Regions
2.2.1 Global Anthrax Vaccines Sales by Regions
2.2.2 Global Anthrax Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anthrax Vaccines Sales by Manufacturers
3.1.1 Anthrax Vaccines Sales by Manufacturers
3.1.2 Anthrax Vaccines Sales Market Share by Manufacturers
3.1.3 Global Anthrax Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Anthrax Vaccines Revenue by Manufacturers
3.2.1 Anthrax Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Anthrax Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Anthrax Vaccines Price by Manufacturers
3.4 Anthrax Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anthrax Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Anthrax Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anthrax Vaccines Sales by Product
4.2 Global Anthrax Vaccines Revenue by Product
4.3 Anthrax Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anthrax Vaccines Breakdown Data by End User
6 North America
6.1 North America Anthrax Vaccines by Countries
6.1.1 North America Anthrax Vaccines Sales by Countries
6.1.2 North America Anthrax Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anthrax Vaccines by Product
6.3 North America Anthrax Vaccines by End User
7 Europe
7.1 Europe Anthrax Vaccines by Countries
7.1.1 Europe Anthrax Vaccines Sales by Countries
7.1.2 Europe Anthrax Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anthrax Vaccines by Product
7.3 Europe Anthrax Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines by Countries
8.1.1 Asia Pacific Anthrax Vaccines Sales by Countries
8.1.2 Asia Pacific Anthrax Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anthrax Vaccines by Product
8.3 Asia Pacific Anthrax Vaccines by End User
9 Central & South America
9.1 Central & South America Anthrax Vaccines by Countries
9.1.1 Central & South America Anthrax Vaccines Sales by Countries
9.1.2 Central & South America Anthrax Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anthrax Vaccines by Product
9.3 Central & South America Anthrax Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Anthrax Vaccines by Countries
10.1.1 Middle East and Africa Anthrax Vaccines Sales by Countries
10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anthrax Vaccines by Product
10.3 Middle East and Africa Anthrax Vaccines by End User
11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Details
11.1.2 Company Business Overview
11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
11.1.5 Emergent BioSolutions Recent Development
11.2 Merial
11.2.1 Merial Company Details
11.2.2 Company Business Overview
11.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merial Anthrax Vaccines Products Offered
11.2.5 Merial Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Anthrax Vaccines Products Offered
11.3.5 Merck Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Company Business Overview
11.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Zoetis Anthrax Vaccines Products Offered
11.4.5 Zoetis Recent Development
11.5 Bayer Sanidad Animal
11.5.1 Bayer Sanidad Animal Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
11.5.5 Bayer Sanidad Animal Recent Development
11.6 Colorado Serum
11.6.1 Colorado Serum Company Details
11.6.2 Company Business Overview
11.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Colorado Serum Anthrax Vaccines Products Offered
11.6.5 Colorado Serum Recent Development
11.7 PharmAthene
11.7.1 PharmAthene Company Details
11.7.2 Company Business Overview
11.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 PharmAthene Anthrax Vaccines Products Offered
11.7.5 PharmAthene Recent Development
11.8 Tiankang
11.8.1 Tiankang Company Details
11.8.2 Company Business Overview
11.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Tiankang Anthrax Vaccines Products Offered
11.8.5 Tiankang Recent Development
11.9 Biogénesis-Bago
11.9.1 Biogénesis-Bago Company Details
11.9.2 Company Business Overview
11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
11.9.5 Biogénesis-Bago Recent Development
11.10 CAVAC
11.10.1 CAVAC Company Details
11.10.2 Company Business Overview
11.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 CAVAC Anthrax Vaccines Products Offered
11.10.5 CAVAC Recent Development
11.11 Rosenbusch
11.12 Agrovet
11.13 Vecol
11.14 CVCRI
11.15 IVPM
11.16 Prondil
11.17 CDV
11.18 Indian Immunologicals
11.19 Botswana Vaccine Institute
11.20 Ceva Santé Animale
11.21 Intervac
11.22 JOVAC
12 Future Forecast
12.1 Anthrax Vaccines Market Forecast by Regions
12.1.1 Global Anthrax Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Anthrax Vaccines Revenue Forecast by Regions 2019-2025
12.2 Anthrax Vaccines Market Forecast by Product
12.2.1 Global Anthrax Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Anthrax Vaccines Revenue Forecast by Product 2019-2025
12.3 Anthrax Vaccines Market Forecast by End User
12.4 North America Anthrax Vaccines Forecast
12.5 Europe Anthrax Vaccines Forecast
12.6 Asia Pacific Anthrax Vaccines Forecast
12.7 Central & South America Anthrax Vaccines Forecast
12.8 Middle East and Africa Anthrax Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anthrax Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Anthrax Vaccines Product Picture
Table Anthrax Vaccines Market Segments
Table Key Manufacturers Anthrax Vaccines Covered
Table Global Anthrax Vaccines Market Size Growth Rate by Product 2019-2025 (M Doses) & (Million US$)
Figure Global Anthrax Vaccines Sales Market Share by Product 2014-2025
Figure Live Vaccines Product Picture
Table Major Manufacturers of Live Vaccines
Figure Cell free PA Vaccines Product Picture
Table Major Manufacturers of Cell free PA Vaccines
Table Global Anthrax Vaccines Market Size Growth Rate by End User 2019-2025 (M Doses)
Figure Human Use
Figure Animal Use
Figure Anthrax Vaccines Report Years Considered
Figure Global Anthrax Vaccines Market Size 2014-2025 (Million US$)
Figure Global Anthrax Vaccines Sales 2014-2025 (M Doses)
Table Global Anthrax Vaccines Market Size by Regions 2014-2019 (M Doses) & (Million US$)
Table Global Anthrax Vaccines Sales by Regions 2014-2019 (M Doses)
Table Global Anthrax Vaccines Sales Market Share by Regions 2014-2019
Figure Global Anthrax Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Anthrax Vaccines Sales Market Share by Regions
Table Global Anthrax Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Anthrax Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Anthrax Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anthrax Vaccines Revenue Market Share by Regions
Table Global Anthrax Vaccines Sales by Manufacturers (2014-2019) (M Doses)
Table Global Anthrax Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Anthrax Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anthrax Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Anthrax Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Anthrax Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Anthrax Vaccines Price (2014-2019) (USD/Doses)
Table Anthrax Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anthrax Vaccines Product Type
Table Date of International Manufacturers Enter into Anthrax Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table Global Anthrax Vaccines Sales Share by Product (2014-2019)
Figure Global Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure Global Anthrax Vaccines Sales Market Share by Product in 2018
Table Global Anthrax Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Anthrax Vaccines Revenue Share by Product (2014-2019)
Figure Global Anthrax Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Anthrax Vaccines Revenue Market Share by Product in 2018
Table Anthrax Vaccines Price by Product 2014-2019 (USD/Doses)
Table Global Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table Global Anthrax Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Anthrax Vaccines Market Share by End User (2014-2019)
Figure Global Sales Anthrax Vaccines Market Share by End User in 2018
Figure North America Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses)
Figure North America Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anthrax Vaccines Sales by Countries (2014-2019) (M Doses)
Table North America Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anthrax Vaccines Sales Market Share by Countries
Table North America Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anthrax Vaccines Revenue Market Share by Countries
Figure United States Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure United States Anthrax Vaccines Revenue Growth Rate (2014-2019) (M Doses)
Figure Canada Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Canada Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Mexico Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table North America Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Anthrax Vaccines Market Share by Product
Table North America Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table North America Anthrax Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Anthrax Vaccines Market Share by End User
Figure Europe Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses)
Figure Europe Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anthrax Vaccines Sales by Countries (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anthrax Vaccines Sales Market Share by Countries
Table Europe Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anthrax Vaccines Revenue Market Share by Countries
Figure Germany Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Germany Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure France Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure UK Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Italy Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Russia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anthrax Vaccines Market Share by Product
Table Europe Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table Europe Anthrax Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anthrax Vaccines Market Share by End User
Figure Asia Pacific Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses)
Figure Asia Pacific Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anthrax Vaccines Sales by Countries (2014-2019) (M Doses)
Table Asia Pacific Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anthrax Vaccines Sales Market Share by Countries
Table Asia Pacific Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anthrax Vaccines Revenue Market Share by Countries
Figure China Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure China Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Japan Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Korea Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure India Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Australia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Indonesia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Malaysia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Philippines Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Thailand Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Vietnam Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Singapore Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table Asia Pacific Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anthrax Vaccines Market Share by Product
Table Asia Pacific Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table Asia Pacific Anthrax Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anthrax Vaccines Market Share by End User
Figure Central & South America Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses)
Figure Central & South America Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anthrax Vaccines Sales by Countries (2014-2019) (M Doses)
Table Central & South America Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anthrax Vaccines Sales Market Share by Countries
Table Central & South America Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anthrax Vaccines Revenue Market Share by Countries
Figure Brazil Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Brazil Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Argentina Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table Central & South America Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anthrax Vaccines Market Share by Product
Table Central & South America Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table Central & South America Anthrax Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anthrax Vaccines Market Share by End User
Figure Middle East and Africa Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses)
Figure Middle East and Africa Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anthrax Vaccines Sales by Countries (2014-2019) (M Doses)
Table Middle East and Africa Anthrax Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anthrax Vaccines Sales Market Share by Countries
Table Middle East and Africa Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries
Figure GCC Countries Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure GCC Countries Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Turkey Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure Egypt Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses)
Figure South Africa Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anthrax Vaccines Sales by Product (2014-2019) (M Doses)
Table Middle East and Africa Anthrax Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anthrax Vaccines Market Share by Product
Table Middle East and Africa Anthrax Vaccines Sales by End User (2014-2019) (M Doses)
Table Middle East and Africa Anthrax Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anthrax Vaccines Market Share by End User
Table Emergent BioSolutions Company Details
Table Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Emergent BioSolutions Recent Development
Table Merial Company Details
Table Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Merial Recent Development
Table Merck Company Details
Table Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Zoetis Company Details
Table Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Zoetis Recent Development
Table Bayer Sanidad Animal Company Details
Table Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Bayer Sanidad Animal Recent Development
Table Colorado Serum Company Details
Table Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Colorado Serum Recent Development
Table PharmAthene Company Details
Table PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table PharmAthene Recent Development
Table Tiankang Company Details
Table Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Tiankang Recent Development
Table Biogénesis-Bago Company Details
Table Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table Biogénesis-Bago Recent Development
Table CAVAC Company Details
Table CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
Table CAVAC Recent Development
Table Rosenbusch Company Details
Table Agrovet Company Details
Table Vecol Company Details
Table CVCRI Company Details
Table IVPM Company Details
Table Prondil Company Details
Table CDV Company Details
Table Indian Immunologicals Company Details
Table Botswana Vaccine Institute Company Details
Table Ceva Santé Animale Company Details
Table Intervac Company Details
Table JOVAC Company Details
Table Global Anthrax Vaccines Sales Forecast by Regions 2019-2025 (M Doses)
Table Global Anthrax Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Anthrax Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anthrax Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Anthrax Vaccines Sales Forecast by Product 2019-2025 (M Doses)
Table Global Anthrax Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Anthrax Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anthrax Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Anthrax Vaccines Sales Forecast by End User 2019-2025 (M Doses)
Table Global Anthrax Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure North America Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Europe Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Asia Pacific Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Central & South America Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Middle East and Africa Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anthrax Vaccines Value Chain
Table Anthrax Vaccines Customers List
Table Anthrax Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
- PRICE
-
$3900$7800